Key words
C. oblonga Mill. - F. carica L. - quince - fig - heart failure - cardiotonic
Introduction
Doxorubicin (DOX), a member of the anthracycline family, is one of the most-used antineoplastic
drugs, being highly active against an extensive variety of malignancies, even at lower
doses [1]. Unfortunately, cardiotoxicity of DOX is the main side effect in 10% of treated
patients, which can cause irreversible heart failure many years after the cessation
of chemotherapy [2]. Several mechanisms are involved in DOX-induced cardiotoxicity, including intracellular
calcium dysregulation, defects in iron handling, and oxidative stress [3].
Accumulating evidence indicates that DOX increases the generation of mitochondrial
reactive oxygen species (ROS) in cardiomyocytes and that the alteration of mitochondrial
function is the principal mechanism of this cardiotoxic effect [4]. It has been also demonstrated that DOX-induced heart failure is mediated by the
reduction/oxidation cycling of DOX to generate superoxide radicals that consequently
trigger mitochondrial swelling, ultrastructural changes, and mitochondrial dysfunction.
These events finally lead to cardiomyocyte cell death that is responsible for cardiac
damage [5]. Considering that a major challenge in managing patients receiving DOX is to reduce
the cardiotoxic effects, it has been suggested that the maintenance of mitochondrial
function plays a key role in protecting against DOX-induced cardiotoxicity [6].
An important aspect of horticulture is the cultivation of plants for food, fiber,
biofuel, medicine and other products used to sustain and enhance human life. Horticulture
was the key development in the rise of sedentary human civilization, whereby farming
of domesticated species created food surpluses that nurtured the development of civilization
[7]
[8]. Cydonia oblonga Mill. fruit, commonly referred to as quince, and Ficus carica L.
fruit, generally referred to as fig, are plants that have been used in Iranian traditional
medicine for the management of cardiovascular diseases [9]. Cydonia oblonga Mill. belongs to the Rosaceae family and has antihypertensive,
antiproliferative, hypolipidaemic, hepatoprotective, and renoprotective effects [10]
[11]
[12]
[13]. Recently, we reported the preventive effect of quince fruit against hepatocellular
carcinoma and against carbon tetrachloride-induced hepatotoxicity [14]
[15]. Ficus carica L. is a member of the Moraceae family and is one of the first plants
to be cultivated by humans. It has various pharmacological properties, including anticancer
and anti-inflammatory [16]. However, the cardioprotective effects of Cydonia oblonga Mill. and Ficus carica L. fruits on cardiotoxicity induced by DOX have not yet been studied.
Thus, this study evaluated the protective roles of the aqueous extracts of Cydonia oblonga Mill. fruit (ACO) and Ficus carica L. fruit (AFC) against DOX-induced
cardiotoxicity. To this end, it was determined whether each particular extract improved
mitochondrial function in mitochondria isolated from the hearts of DOX-treated rats.
Materials and Methods
Chemicals
DOX hydrochloride was obtained from ACCORD HEALTHCARE (France). 4-2-hydroxyethyl-1-piperazineethanesulfonic
acid (HEPES), reduced glutathione (GSH), 2’,7’-dichlorofluorescin diacetate (DCFH-DA),
dithiobis-2-nitrobenzoic acid (DTNB), Tris-HCl, sulfuric acid, Tetramethoxypropane
(TMP), and Rhodamine 123 (Rh 123) were purchased from Sigma- Aldrich Co. (Taufkrichen,
Germany). All chemicals were of analytical, HPLC or the best pharmaceutical grades.
Plant materials, preparation of the extracts
Cydonia oblonga Mill. and Ficus carica L. fruits were collected from Shahriar, Alborz
province, Iran and Estahban, Fars Province, Iran, respectively. The collected fruits
were scientifically approved by the Department of Botany, Shahid Beheshti University
(Voucher number: 8 054 for Cydonia oblonga Mill. and 8 072 for Ficus carica L., deposited in: Shahid Beheshti University Herbarium). The fresh fruits
were cleaned and then dried in the shade at room temperature. Fruits were decocted
in water for 30 min. Accordingly, the extract was filtered, concentrated to the desired
level (honey-like viscosity), and stored at −20°C. The moisture level of the extract
was determined by placing 2 g of the final extract in an oven at 60–65°C for 72 h
and then weighing it. Weight loss was used as a moisture indicator. The final extract
contained 24% water. These extracts were dissolved in distilled water at the desired
concentrations just before use [17]
[18]. Total phenolic contents were found to be 43.42±1.18 and 13.57±0.28 mg gallic acid
equivalents (GAE) per gram of ACO and AFC (mg of GAE/g of plant extract), respectively.
The given values are mean±SD of 3 different determinations.
Determination of total polyphenol contents
Total polyphenol contents were determined by spectrophotometry, using gallic acid
as the standard based on the Folin–Ciocalteu method as previously described (Pearson’s
correlation coefficient: r2=0.9906) [19].
Animals
Male Sprague-Dawley rats weighing 200 to 250 g were housed in ventilated plastic cages
over PWI 8–16 hardwood bedding. There were 12 air changes per h, 12 h light photoperiods,
an environmental temperature of 21–23°C, and a relative humidity of 50–60%. The animals
were fed a standard normal chow diet and given tap water ad libitum. Principles of
laboratory animal care (NIH publication No. 85-23, revised 1985) were followed. All
experiments were conducted according to the ethical standards and protocols approved
by the Committee of Animal Experimentation of Zanjan University of Medical Sciences,
Zanjan, Iran.
Experimental protocol and study design
60 rats were randomly selected for the control group, and the remaining 60 rats received
DOX to induce heart failure. DOX was administrated intraperitoneally (i.p.) in 6 equal
injections (each containing 2.5 mg/kg) on alternate days over a period of 2 weeks
for a cumulative dose of 15 mg/kg [20]. At the end of this period, heart failure in the surviving rats was confirmed through
serum Big-endothelin-1 levels evaluated using the Big Endothelin-1 ELISA kit as a
marker of the degree of left ventricular dysfunction [21]. At the end of the experimental period, rats were sacrificed and their cardiac mitochondria
were isolated by differential ultracentrifugation. In the first step, the functions
of the cardiac mitochondria isolated from normal rats and heart failure rats were
compared. Then, the protective effects of quince and fig fruit extracts on mitochondrial
function were evaluated in mitochondria isolated from the heart of DOX-treated rats.
We chose a wide range of concentrations for the ACO and AFC in our pilot study and
their inhibitory effects against DOX-induced mitochondrial toxicity were evaluated
(data not shown). By omitting non-effective, poorly effective or toxic concentrations,
we selected the concentrations of 50 and 100 μg/ml for ACO and 100 and 200 μg/ml for
AFC. The extracts were added to the mitochondria 20 min before the measurement of
mitochondrial factors.
Isolation of cardiac mitochondria
Rat heart mitochondria were isolated according to the previously published protocols
with some modifications [22]. Rats were anaesthetized with i.p. injections of ketamine (50 mg/kg) and xylazine
(10 mg/kg). For each rat, the thoracic cavity was opened and the heart removed. The
heart was carefully separated from its surrounding connective tissues and vessels,
minced and washed in a cold MSE buffer (mannitol solution containing 0.225 M D-mannitol,
75 mM sucrose and 0.2 mM EDTA, pH=7.4) sufficiently to remove blood (until the washing
fluid became colorless). To isolate the mitochondria, the separated heart was homogenized
in a glass homogenizer with a Teflon pestle using a tissue homogenizer for 1 min at
4°C. The homogenates were centrifuged at 2 000×g for 10 min, and then the obtained
supernatants were centrifuged at 10 000×g for 10 min. The final mitochondrial pellet
was preserved in a special buffer relative to every experiment. Mitochondria were
isolated freshly for each experiment and used within 4 h of isolation, and all steps
were strictly worked on ice to guarantee the isolation of high quality mitochondrial
preparations. The isolation of mitochondria was established by the measurement of
succinate dehydrogenase (SDH) activity [23].
Determination of protein concentration
The concentration of mitochondrial protein was measured by the Coomassie blue protein-binding
method using BSA as the standard [24]. To keep the uniformity of experimental conditions, the mitochondrial samples were
used in the same concentration (500 μg protein/mL) in all experiments.
Determination of mitochondrial ROS formation
To determine the level of mitochondrial ROS generation, DCFH-DA was added to the isolated
mitochondria. It penetrated mitochondria and was hydrolyzed to nonfluorescent dichlorofluorescin
(DCFH). This compound which is nonfluorescent in turn reacted with ROS and forms highly
fluorescent dichlorofluorescein (DCF), which effluxed the mitochondria. The fluorescence
intensity of DCF in the medium was measured using a HITACHI fluorescence spectrophotometer.
Excitation and emission wavelengths were 500 and 520 nm, respectively. The fluorescence
intensity of the isolated cardiac mitochondria (500 μg/ml protein concentration) in
respiratory buffer containing 10 mM Tris, 0.32 mM sucrose, 0.5 mM MgCl2, 20 mM MOPS, 0.05 mM EGTA, 0.1 mM KH2PO4, and 5 mM sodium succinate and DCFH-DA (final concentration of 10 μM) was documented
[25].
Mitochondrial reduced glutathione assay
The level of glutathione (GSH) in the heart mitochondrial fraction (500 μg protein/mL)
was estimated by a spectrophotometric method using DTNB as the indicator of GSH [26]. The intensity of the yellow color produced in the samples was recorded at 412 nm
with a UV spectrophotometer (Infinite M 200, TECAN). GSH content was expressed as
µg/mg protein.
Measurement of mitochondrial lipid peroxidation
The amount of malondialdehyde (MDA) as the marker of lipid peroxidation was measured
by reading the absorbance of the supernatant layer at 532 nm with an ELISA reader
instrument (Infinite M 200, TECAN). TMP was used as the standard sample, and MDA content
was expressed as µg/mg protein [27].
Succinate dehydrogenase activity assay
The activity of succinate dehydrogenase (mitochondrial complex II) was determined
by measuring the reduction of MTT to formazan at 570 nm using an ELISA reader instrument
(Infinite M 200, TECAN) [28].
Estimation of mitochondrial membrane potential (MMP)
In the present study, we used a rhodamine 123 exclusion assay to detect the membrane
potential of cells due to its selective accumulation and quenching in mitochondria.
Loss of the membrane potential will lead to release of the dye and, consequently,
the fluorescence intensity [29]. Our data were shown as the percentage of MMP collapse (%ΔΨm) in all treated groups.
CaCl2 (50 mM), a known inducer of mitochondrial permeability transition (MPT) and MMP collapse
was used as a positive control.
Mitochondrial swelling assessment
The swelling of mitochondria as a result of the transport of ions into the mitochondria
was assessed through changes in light scattering using a spectrophotometer ELISA reader
(Infinite M 200, TECAN) set at 540 nm. The absorbance of the samples was monitored
for 1 h [28]. CaCl2 (50 mM), a known inducer of MPT was used as a positive control.
Determination of cytochrome c release
Cytochrome c released from mitochondria was measured by rat/mouse cytochrome c ELISA
Kit (Quantikine M., R&D Systems, Abingdon, UK) according to the manufacturer’s instructions.
This test employs the quantitative sandwich enzyme immunoassay technique and is designed
to accurately quantify natural rat or mouse cytochrome c in cell lysates and subcellular
fractions [30].
Statistical analysis
The homogeneity of variances was tested using Levene’s test. The results were expressed
as the mean±SD of triplicate samples (n=3) using one way analysis of variance (ANOVA)
followed by Tukey’s post hoc test. The results with level of significance (P<0.05)
were regarded as significant.
Results
Effects of ACO and AFC treatments on mitochondrial ROS formation
As shown in [Fig. 1], ROS production determined by the oxidation of DCFH-DA to DCF was increased in the
isolated heart mitochondria of DOX-induced heart failure rats compared with those
of normal rats (P<0.001). ACO and AFC, at concentrations of 100 µg/ml and 200 µg/ml,
respectively, significantly (P<0.05) prevented ROS formation in the mitochondria of
DOX-treated rats after 30 min of incubation ([Fig. 1]).
Fig. 1 Effects of ACO and AFC on mitochondrial ROS production in isolated heart mitochondria.
DCF formation was expressed as fluorescent intensity units (FI units) and was shown
as the percentage of fold increase from control group. Values are expressed as the
mean±SD of 3 separate experiments (n=3). *** P < 0.001 compared with isolated heart
mitochondria of normal rats (Control group) in the same time; Ф P<0.05 compared with
isolated heart mitochondria of DOX-treated rats (DOX group).
Effects of ACO and AFC treatments on mitochondrial GSH levels
GSH and its related antioxidant defense system prevent oxidative damage of lipids
and other biomolecules caused by free radicals and have crucial roles in the maintenance
of intracellular and intramitochondrial homeostasis. GSH levels were decreased in
isolated heart mitochondria of DOX-treated rats compared with the control mitochondria
(P<0.01). Again, a decrease in mitochondrial GSH content was prevented by ACO at concentrations
of 50 and 100 µg/ml and AFC (200 µg/ml) in the mitochondria of rats receiving DOX
following 60 min of incubation (P<0.05) ([Fig. 2]).
Fig. 2 Effects of ACO and AFC on mitochondrial GSH content in isolated heart mitochondria.
GSH levels were determined using DTNB reagent as indicator of reduced glutathione
following 60 min of incubation. Values are expressed as the mean±SD of 3 separate
experiments (n=3). ** P<0.01 compared with isolated heart mitochondria of normal rats
(Control group); Ф P<0.05 compared with isolated heart mitochondria of DOX-treated
rats (DOX group).
Effects of ACO and AFC treatments on mitochondrial lipid peroxidation
Lipid peroxidation is usually one of the important consequences of ROS formation and
oxidative stress in biological systems. The current results showed that lipid peroxidation
also occurred in the mitochondria of DOX-induced heart failure rats, and a significantly
(P<0.001) increased amount of MDA was formed as compared with those of control group.
MDA concentrations were decreased when the mitochondria were incubated with ACO and
AFC at concentrations of 100 µg/ml and 200 µg/ml, respectively, following 60 min of
incubation (P<0.05) ([Fig. 3]).
Fig. 3 Effects of ACO and AFC on lipid peroxidation in isolated heart mitochondria. MDA
formation as the marker of lipid peroxidation was expressed as µg/mg protein following
60 min of incubation. Values are expressed as the mean±SD of 3 separate experiments
(n=3).***P<0.001 compared with isolated heart mitochondria of normal rats (Control
group); Ф P<0.05 compared with isolated heart mitochondria of DOX-induced heart failure
rats (DOX group).
Effects of ACO and AFC treatments on complex II activity
Succinate dehydrogenase (complex II) is responsible for most cellular reduction and
is the main site of MTT reduction in the mitochondrial fraction. The MTT assay is
considered a succinate dehydrogenase inhibition assay. The activity of complex II
showed a significant reduction (P<0.01) in heart mitochondria of rats receiving DOX
as determined by the formation of formazan. In addition, the pretreatment of mitochondria
with ACO and AFC at concentrations of 100 µg/ml and 200 µg/ml, respectively, increased
SDH activity following 60 min of incubation (P<0.05) ([Fig. 4]).
Fig. 4 Effects of ACO and AFC on succinate dehydrogenase (complex II) activity in isolated
heart mitochondria. Succinate dehydrogenase activity was measured using MTT dye following
60 min of incubation. Values are expressed as the mean±SD of 3 separate experiments
(n=3). ** P<0.01 compared with isolated heart mitochondria of normal rats (Control
group); Ф P<0.05 compared with isolated heart mitochondria of DOX-induced heart failure
rats (DOX group).
Effects of ACO and AFC treatments on MMP
MMP decline is the concluding marker of mitochondrial toxicity in all mitochondrial
damaging pathways. As shown in [Table 1], MMP (%ΔΨm) was decreased in isolated heart mitochondria of rats receiving DOX as
compared with the control mitochondria (P<0.001). Elevated levels of %ΔΨm were prevented
by ACO and AFC at the concentrations of 100 µg/ml and 200 µg/ml, respectively (P<0.05)
([Table 1]).
Table 1 Effect of ACO and AFC on mitochondrial membrane potential collapse (%ΔΨ) in isolated
heart mitochondria.
|
Addition
|
%ΔΨ
|
|
Incubation time
|
|
5 min
|
15 min
|
30 min
|
45 min
|
60 min
|
|
Control
|
0
|
9.2±1.7
|
21.8±1.8
|
34.4±2.3
|
39.9±3.1
|
|
+CaCl2
|
13.1±0.6***
|
21.8±1.7***
|
56.7±1.7***
|
73.4±2.5***
|
80.7±3.3***
|
|
DOX
|
8.3±0.9***
|
18.2±1.5*
|
32.1±1.9***
|
44.4±2.6**
|
58.9±3.5***
|
|
+ACO (50 µg/ml)
|
6.9±1.2
|
14.8±1.3
|
27.7±1.6
|
40.7±1.9
|
54.7±2.7
|
|
+ACO (100 µg/ml)
|
8.1±1.0
|
13.4±1.7 Φ
|
25.06±1.9 Φ
|
38.3±2.4 Φ
|
51.5±2.9
|
|
+AFC (100 µg/ml)
|
7.9±1.0
|
16.3±1.0
|
29.8±1.5
|
42.1±2.6
|
57.8±1.34
|
|
+AFC (200 µg/ml)
|
7.5±0.9
|
14.5±1.2 Φ
|
26.9±1.4 Φ
|
40.05±2.8
|
53.2±3.3
|
Mitochondrial membrane potential was determined as the difference in mitochondrial
uptake of rhodamine 123 between control and treated mitochondria. Our data were shown
as the percentage of mitochondrial membrane potential collapse (%ΔΨ) in all treated
(test) groups. Values are expressed as the mean±SD of 3 separate experiments (n=3).
* P<0.05;** P<0.01;***P<0.001 compared with isolated heart mitochondria of normal
rats (Control group) in the same time; Ф P<0.05 compared with isolated heart mitochondria
of DOX-treated rats (DOX group).
Effects of ACO and AFC treatments on swelling
Mitochondrial swelling reflects the opening of mitochondrial ion channels and membrane
pores which was evaluated through monitoring the changes in the absorbance of mitochondrial
samples at 540 nm. Reduced absorbance is related to increase in mitochondrial swelling.
The current results showed that there was significant decrease (P<0.001) in absorbance
in the heart mitochondria of DOX-treated rats as compared with the control mitochondria.
Similarly, ACO and AFC, at concentrations of 100 µg/ml and 200 µg/ml, respectively,
prevented swelling in the mitochondria of DOX-treated rats (P<0.001) ([Fig. 5]).
Fig. 5 Effects of ACO and AFC on mitochondrial swelling in isolated heart mitochondria.
Mitochondrial swelling was measured as optical density (OD) by determination of absorbance
at 540 nm. Values are expressed as the mean±SD of 3 separate experiments (n=3). ***
P<0.001 compared with isolated heart mitochondria of normal rats (Control group) in
the same time; Ф P<0.05; ФФ P<0.01; ФФФ P<0.001 compared with isolated heart mitochondria
of DOX-treated rats (DOX group).
Effects of ACO and AFC treatment on cytochrome c release
The release of cytochrome c from mitochondria is the endpoint of mitochondrial toxicity
which starts cell death signaling.Cytochrome c release occurred in the heart mitochondria
of DOX-induced heart failure rats compared with the control mitochondria (P<0.001).
This toxic event was prevented by ACO and AFC, at the concentrations of 100 µg/ml
and 200 µg/ml, respectively following 60 min of incubation (P<0.01 for ACO and P<0.05 for AFC) ([Fig. 6]).
Fig. 6 Effects of ACO and AFC on cytochrome c release in isolated heart mitochondria. The
amount of expelled cytochrome c from mitochondrial fraction was determined using Rat/Mouse
cytochrome c ELISA kit following 60 min of incubation. Values are expressed as the
mean±SD of 3 separate experiments (n=3). *+*+* p<0.001 compared with isolated heart
mitochondria of normal rats (Control group); Ф P<0.05; ФФ P<0.01 compared with isolated
heart mitochondria of DOX-induced heart failure rats (DOX group).
Discussion
DOX is the most effective anticancer drug used in the treatment of various types of
cancer. Unfortunately, its clinical utility is limited by the development of severe
cardiotoxicity that results in cardiomyopathy and heart failure. So, many strategies
have been tried to prevent or attenuate the cardiotoxic effects of DOX in cancer patients.
However, the ability of strategies to prevent or ameliorate the cardiotoxicity has
been limited and discovery of new agents for decreasing the most dangerous side effect
of DOX is necessary [5]
[31].
Diverse mechanisms are involved in DOX-induced cardiotoxicity, but it has been suggested
that mitochondria have a crucial role in the DOX cardiac toxicity mechanisms. DOX
has a high affinity for mitochondrial membrane and therefore accumulates inside the
mitochondria. Due to its high redox potential, DOX diverts electrons from complex
I of the respiratory chain. Consequently, redox cycling of quinone-semiquinone moiety
of DOX leads to the production of ROS and oxidative stress which alerts cardiomyocytes-specific
gene expression [5]
[32]. Therefore, many attempts have been made to reduce the cardiotoxic effects of DOX
through ameliorating mitochondrial dysfunction. Results of the current study showed
that the mitochondrial dysfunction markers were elevated in isolated heart mitochondria
of DOX-induced heart failure rats in comparison with those of normal rats. These results
are consistent with previously published results that have demonstrated mitochondrial
oxidative stress and dysfunction are the principal mechanisms of DOX cardiotoxic effects
[4].
The interaction of excessive ROS and diverse mitochondrial macromolecules causes GSH
depletion and lipid peroxidation. GSH has a strategic role in the maintenance of suitable
redox environment of mitochondria through neutralizing hydrogen peroxide, lipid hydroperoxides,
electrophiles, and xenobiotics. Therefore, the depletion of mitochondrial GSH accounts
a serious threat to the cell which oxidatively modifies different mitochondrial macromolecules
such as lipid, proteins, and DNA. Lipid peroxidation of biomambranes happens in the
mitochondria as a result of GSH depletion and oxidative stress. This toxic event inactivates
different mitochondrial components such as respiratory chain enzymes and causes mitochondrial
dysfunction. Succinate dehydrogenase or respiratory complex II is one of these enzymes
that its activity decreases in oxidative stress and the subsequent toxic events. It
plays unique role in mitochondrial function and is the only enzyme that contributes
in both the citric acid cycle and the electron transport chain. Thus, any impairment
of complex II leads to ROS production and the potentiation of oxidative stress [33]. In the present study, the protective effects of ACO and AFC on cardiomyocyte mitochondrial
oxidative stress in a rat model of DOX-induced cardiotoxicity were also investigated.
The protective effect of different antioxidants on DOX-induced cardiac injury supports
the essential role of oxidative stress in the toxicity [6]
[34]. Results of this study indicated that ACO and AFC ameliorated mitochondrial oxidative
stress by preventing ROS production and membrane lipid peroxidation as well as elevating
GSH content and succinate dehydrogenase activity in the isolated heart mitochondria
of rats receiving DOX.
Elevated ROS in DOX cardiotoxicity can also attack the thiol cross-linking of the
MPT pore region and increase permeability. The opening of MPT pores can lead to MMP
collapse (ΔΨm) and mitochondrial swelling. The current results showed that ACO and
AFC effectively prevented MMP decrease (%ΔΨm) and mitochondrial swelling as final
markers of mitochondrial dysfunction. Release of cytochrome c from mitochondria into
cytosol following MPT pore opening is a crucial initiating phase in both apoptotic
and necrotic cell death processes in intact cells which are responsible for cardiac
damage [5]. In this study, ACO and AFC prevented the release of cytochrome c from the isolated
heart mitochondria of rats which leads to apoptosis or necrosis pending on the cellular
ATP level. However, ACO was much more effective than AFC at ameliorating the markers
of mitochondrial dysfunction in isolated heart mitochondria of DOX-treated rats simply
because the effective concentration of ACO was 100 µg/ml compared with the 200 µg/ml
concentration of AFC.
Quince and fig have been used in Iranian traditional medicine for the prevention and
treatment of cardiovascular diseases [9]. Quince (Cydonia oblonga Mill.) contains polyphenols, organic acids, and free amino
acids [35]
[36]
[37]. Fig (Ficus carica L.) possesses antioxidant activity and is a source of phenolic and flavonoid
compounds, alkaloids, terpenoids, and saponins [38]
[39]. Results of the current study suggest that the bioactive compounds from quince and
fig would be valuable for their potential use in the prevention and treatment of heart
diseases. It can be also suggested that the cardioprotective effects of quince and
fig against DOX-induced cardiotoxicity are partly mediated by their antioxidant effects.
Antioxidant supplements improve the benefits of treatment in cancer patients and reduce
certain forms of toxicity associated with chemotherapy [40]. However, the authors believe that further in vivo and in vitro studies are required to clarify what active constituents are responsible for the
cardioprotective effects of the 2 edible fruits and to fully explain the mechanisms
underlying the effects.
Conclusion
Mitochondrial dysfunction has been involved in DOX-induced cardiotoxic effects. The
results of the current research showed that ACO and AFC ameliorate the impairment
of cardiac mitochondrial function in DOX-treated rats by preventing mitochondrial
ROS generation, lipid peroxidation, swelling, membrane potential decrease (%ΔΨm),
and cytochrome c release and also by elevating mitochondrial GSH and complex II activity.
Therefore, quince and fig show potentials to be considered as safe and suitable candidates
in managing cancer patients receiving DOX.
